634-03-7 Usage
Description
Phendimetrazine is an amphetamine derivative and a controlled substance classified as a stimulant. It is a pale yellow oil with various brand names and is primarily used for its appetite-suppressing properties.
Uses
Used in Pharmaceutical Industry:
Phendimetrazine is used as an appetite suppressant for the treatment of obesity. It helps individuals control their food intake by reducing appetite, which in turn aids in weight management and weight loss efforts.
Used in Research and Development:
Phendimetrazine is also used in research and development for studying the effects of stimulants on the central nervous system and their potential applications in various medical conditions.
World Health Organization (WHO)
Phendimetrazine, a sympathomimetic amine, was introduced in
1961 for use as an anorexic agent. It retains a place in the treatment of obesity.
However, since it has been subject to abuse and because dependence can occur,
phendimetrazine is controlled under Schedule IV of the 1971 Convention on
Psychotropic Substances.
(Reference: (UNCPS4) United Nations Convention on Psychotropic Substances (IV),
, , 1971)
Check Digit Verification of cas no
The CAS Registry Mumber 634-03-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,3 and 4 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 634-03:
(5*6)+(4*3)+(3*4)+(2*0)+(1*3)=57
57 % 10 = 7
So 634-03-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3/t10-,12+/m0/s1
634-03-7Relevant articles and documents
Facile, efficient, and catalyst-free electrophilic aminoalkoxylation of olefins: Scope and application
Zhou, Ling,Tan, Chong Kiat,Zhou, Jing,Yeung, Ying-Yeung
supporting information; experimental part, p. 10245 - 10247 (2010/09/07)
A new one-pot electrophilic aminoalkoxylation reaction using olefin, cyclic ether, amine, and N-bromosuccinimide has been developed. The olefinic substrates and the cyclic ether partners can be flexibly varied to produce a range of amino ether derivatives. This novel protocol has been applied in the facile and efficient synthesis of biologically active morpholine compounds.
2.3.4-Trisubstituted morpholines
Schmauder,Groeger,Foken
, p. 17 - 20 (2007/10/07)
-